A Critical Review of CAR-T Therapies for Glioblastoma: What’s Wrong with the Current Attempts?
Today, CAR-T therapy has been widely acknowledged as a “gold standard” treatment for certain hematologic diseases. There is a relatively small but enhancing body of clinical trials studying the effectiveness of CAR-T in treating glioblastoma, known as the most common and aggressive brain tumor in ad...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| coleção: | Hematology/Oncology and Stem Cell Therapy |
| Assuntos: | |
| Acesso em linha: | https://journals.lww.com/10.4103/hemoncstem.HEMONCSTEM-D-24-00040 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|